The effectiveness of PD-L1 immunotherapy for cancer patients can be improved, according to research.

Published Date: 12 Jul 2023

Researchers and oncologists are one step closer to better understanding the complexities of PD-1 inhibitors, a popular form of immunotherapy, thanks to a recent study that was published in the JNCI: Journal of the National Cancer Institute.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot